LGC at AMP 2026
Nov 10–14, 2026 Seattle, WA ~2k attendees Website
LGC brings 1 presentation to AMP 2026 in Seattle, and exhibits at Booth 1804, MR13. Its program centres on reference materials and best practice for tumor-agnostic measurable residual disease testing. The company supplies quality controls, diagnostic panels, sequencing controls and proficiency testing to clinical laboratories through its SeraCare business.
| Organization | AMP 2026 Attendance |
|---|---|
LGC Teddington, UK | |
Quality controls, reference materials, diagnostic panels, NGS controls and proficiency testing for clinical laboratories, through its SeraCare clinical diagnostics business. | Booth Exhibiting at Booth 1804, MR13 Thu, Nov 1211:15am–7:00pmFri, Nov 139:00am–4:00pmSat, Nov 149:00am–1:30pm Workshop Wed, Nov 11 12:00pm–12:50pm You’re So Naïve: Best Practices and Gold-Standard Reference Material for Tumor-Agnostic MRD Testing Tumor-agnostic residual disease assays face validation hurdles, weighed against tumor-informed testing alongside reference materials. |
Instantly find 20 buyers from LGC
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with the Association for Molecular Pathology. Organization details are derived from AMP’s published lists. Submit a correction